ContraFect Corp

Company Profile

ContraFect Corp had its IPO on 2014-07-29 under the ticker symbol CFRX.

The company operates in the Healthcare sector and Biotechnology industry. ContraFect Corp has a staff strength of 23 employees.

Stock update

Shares of ContraFect Corp opened at $0.67 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.66 - $0.72, and closed at $0.66.

This is a -4.19% slip from the previous day's closing price.

A total volume of 29,949 shares were traded at the close of the day’s session.

In the last one week, shares of ContraFect Corp have slipped by -11.85%.

ContraFect Corp's Key Ratios

ContraFect Corp has a market cap of $5.40 million, indicating a price to book ratio of 0.4405 and a price to sales ratio of 0.

In the last 12-months ContraFect Corp’s revenue was $0 with a gross profit of $-1606434 and an EBITDA of $-49612000. The EBITDA ratio measures ContraFect Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ContraFect Corp’s operating margin was 0% while its return on assets stood at -81.22% with a return of equity of -345.24%.

In Q1, ContraFect Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ContraFect Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-1025.87 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ContraFect Corp’s profitability.

ContraFect Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.163. Its price to sales ratio in the trailing 12-months stood at 0.

ContraFect Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$20.55 million

Total Liabilities

$19.65 million

Operating Cash Flow

$0

Capital Expenditure

$5000

Dividend Payout Ratio

0%

ContraFect Corp ended 2024 with $20.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.55 million while shareholder equity stood at $-3137000.00.

ContraFect Corp ended 2024 with $0 in deferred long-term liabilities, $19.65 million in other current liabilities, 1000.00 in common stock, $-327076000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $11.87 million and cash and short-term investments were $13.89 million. The company’s total short-term debt was $674,000 while long-term debt stood at $0.

ContraFect Corp’s total current assets stands at $17.70 million while long-term investments were $0 and short-term investments were $2.03 million. Its net receivables were $0 compared to accounts payable of $10.83 million and inventory worth $0.

In 2024, ContraFect Corp's operating cash flow was $0 while its capital expenditure stood at $5000.

Comparatively, ContraFect Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.66

52-Week High

$363.2

52-Week Low

$0.9

Analyst Target Price

$190

ContraFect Corp stock is currently trading at $0.66 per share. It touched a 52-week high of $363.2 and a 52-week low of $363.2. Analysts tracking the stock have a 12-month average target price of $190.

Its 50-day moving average was $1.04 and 200-day moving average was $3.48 The short ratio stood at 0.02 indicating a short percent outstanding of 0%.

Around 152.9% of the company’s stock are held by insiders while 895% are held by institutions.